Mirum Pharmaceuticals (MIRM) Cash from Investing Activities (2019 - 2026)

Mirum Pharmaceuticals' Cash from Investing Activities history runs 8 years deep, the most recent figure standing at -$11.6 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities rose 28.29% year-over-year to -$11.6 million; the TTM figure through Mar 2026 stood at -$19.4 million (up 81.75% YoY), while the FY2025 annual figure was -$24.0 million, up 73.42% from the prior year.
• Cash from Investing Activities was -$11.6 million for Q1 2026 at Mirum Pharmaceuticals, down from $1.0 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $50.5 million in Q2 2023 to a low of -$182.8 million in Q3 2023.
• Historically, Cash from Investing Activities has averaged -$13.2 million across 5 years, with a median of -$2.0 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities jumped 211.33% in 2022, then tumbled 124007.69% in 2025.
• A 5-year view of Cash from Investing Activities shows it stood at $26.8 million in 2022, then plunged by 107.47% to -$2.0 million in 2023, then jumped by 132.05% to $641000.0 in 2024, then surged by 56.94% to $1.0 million in 2025, then tumbled by 1250.0% to -$11.6 million in 2026.
• The last three Cash from Investing Activities figures came in at -$11.6 million (Q1 2026), $1.0 million (Q4 2025), and -$2.2 million (Q3 2025), per Business Quant data.